SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-22-080239
Filing Date
2022-12-15
Accepted
2022-12-15 19:10:59
Documents
2
Period of Report
2022-12-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1653
2 POWER OF ATTORNEY ea170303ex24_inmedpharm.htm EX-24 7725
  Complete submission text file 0001213900-22-080239.txt   10692
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Issuer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address
Tegge Jonathan (Reporting) CIK: 0001755310 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39685 | Film No.: 221466109